GNRSU Stock Crashes 99.99% on Pink Sheets, Cannabis Firm Faces Delisting Risk

GNRSU stock has collapsed to near-zero levels, trading at just $0.000001 on the Pink Sheets (PNK) exchange. The Greenrose Holding Company Inc., a medical cannabis producer based in Amityville, New York, has experienced a devastating 99.99% decline from its previous close of $0.15. This catastrophic drop reflects severe financial distress at the company, which cultivates and processes cannabis products. With a market cap of just $13 and trading volume of only 145 shares, GNRSU stock now represents one of the market’s most distressed securities. Investors should understand the critical risks before considering any position in this penny stock.

GNRSU Stock Price Collapse: What Happened

GNRSU stock has experienced a complete market failure. The price dropped from $0.15 to $0.000001 in a single trading session, erasing virtually all shareholder value. This represents a 99.99933% loss in one day. The 52-week high was $0.151, but the stock now trades at its 52-week low. With only 145 shares trading and a market cap of $13, GNRSU has become essentially worthless on the open market.

The company’s financial metrics reveal why investors fled. The current ratio sits at just 0.21, meaning Greenrose has only 21 cents in current assets for every dollar of current liabilities. Working capital stands at negative $103.4 million, indicating severe operational stress. These numbers suggest the company cannot meet its short-term obligations and faces potential bankruptcy.

Financial Distress Signals in GNRSU Analysis

Deep analysis of GNRSU stock reveals multiple red flags. The debt-to-equity ratio is 1.57, showing the company carries substantial debt relative to shareholder equity. Tangible book value per share is negative at negative $7.24, meaning liabilities exceed tangible assets. The company’s net current asset value is negative $142.5 million.

Despite these alarming metrics, some ratios appear distorted by the stock’s near-zero price. The P/E ratio of 0.0000895 and price-to-book ratio of 0.0000232 are artificially low due to the collapsed stock price, not fundamental strength. The company reported EPS of $3.097, but this cannot offset the balance sheet deterioration. Track GNRSU on Meyka for real-time updates on this distressed security.

Greenrose Holding Company Operations and Challenges

The Greenrose Holding Company Inc. operates as a specialty cannabis producer in the healthcare sector. Founded in 2014 and headquartered in Amityville, New York, the company employs 910 people. CEO Nicole Conboy leads operations focused on cultivating, processing, and packaging medical cannabis products.

However, operational metrics show the company struggles with efficiency. Inventory turnover is just 0.83, meaning products sit in inventory for 439 days on average. Days sales outstanding is 17 days, but the company’s ability to convert sales into cash is hampered by negative working capital. The company generates $1.58 in revenue per share but cannot translate this into profitability given its debt burden and operational inefficiencies.

Market Sentiment and Trading Activity for GNRSU Stock

Trading activity in GNRSU stock has become virtually nonexistent. Daily volume stands at just 145 shares, with no meaningful average volume data available. This illiquidity means investors cannot easily exit positions, even at the depressed $0.000001 price. The bid-ask spread is likely enormous, making any transaction difficult.

Liquidation pressure appears severe. The stock has declined 99.99% over one day, 99.99% over five days, and 99.99% over the past year. This consistent pattern suggests ongoing forced selling or margin calls. With a market cap of only $13, institutional investors have abandoned the stock entirely. The Pink Sheets listing indicates GNRSU no longer meets exchange standards for major markets.

Meyka AI Grade and Valuation Assessment

Meyka AI rates GNRSU with a grade of B based on a score of 63.42 out of 100. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The HOLD suggestion reflects the stock’s distressed state and extreme risk profile.

Valuation metrics are unreliable given the stock’s near-zero price. The enterprise value is $101.4 million while market cap is only $13, creating an EV-to-sales ratio of 3.99. The Graham Number, a fundamental valuation metric, suggests fair value around $10.39 per share. However, this theoretical valuation is meaningless given the company’s negative tangible book value and working capital crisis. These grades are not guaranteed and we are not financial advisors.

Risks and Delisting Concerns for GNRSU Stock

GNRSU stock faces existential risks including potential delisting from the Pink Sheets. Trading at $0.000001 with minimal volume, the company likely violates exchange listing standards. Reverse stock splits or bankruptcy proceedings may be imminent. Shareholders could face complete loss of investment or severe dilution from restructuring.

The cannabis industry faces regulatory uncertainty, and Greenrose’s financial distress makes it vulnerable to any adverse regulatory changes. With 12.85 million shares outstanding and negative equity, the company may need emergency financing or asset sales. Creditors may force liquidation. Any investment in GNRSU stock should be considered extremely speculative and suitable only for investors who can afford total loss.

Final Thoughts

GNRSU stock represents an extreme cautionary tale in penny stock investing. The 99.99% collapse from $0.15 to $0.000001 reflects fundamental business failure at The Greenrose Holding Company Inc. Negative working capital of $103.4 million, a current ratio of 0.21, and negative tangible book value signal insolvency. The company cannot meet short-term obligations and faces likely delisting from the Pink Sheets exchange. While Meyka AI assigns a B grade with a HOLD rating, this reflects the stock’s distressed valuation rather than investment merit. The 145-share daily volume indicates complete illiquidity, trapping any remaining shareholders. Cannabis industry headwinds combined with Greenrose’s balance sheet crisis create a perfect storm. Investors should avoid GNRSU stock unless prepared for total loss. The company’s 910 employees and operations in Amityville, New York may face restructuring or bankruptcy. Monitor official company announcements for delisting notices or restructuring plans. This stock exemplifies why due diligence and risk management are essential in penny stock markets.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.